Syngene International accepts Kush Parmar's resignation as Independent Director
Syngene International Limited accepted Kush Parmar's resignation as Independent Director effective July 29, 2026, due to his US-based commitments. Parmar also steps down from the Risk Management and Science and Technology Committees. The move complies with SEBI Listing Regulations, with no other material reasons cited.
*this image is generated using AI for illustrative purposes only.
Syngene International has accepted the resignation of Kush Parmar as an Independent Director on its Board, effective from the close of business hours on July 29, 2026. The change follows Parmar’s decision to step down due to increasing commitments in the United States and his inability to devote sufficient time to the company while residing outside India. Consequently, Parmar will also cease to be a member of the Risk Management Committee and the Science and Technology Committee.
The Board placed the resignation on record pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III. The disclosure was made to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). The company confirmed that there are no other material reasons for the resignation beyond those stated in Parmar’s letter.
Resignation Details
Kush Parmar, identified by DIN 09212020, tendered his resignation citing personal professional constraints. His address is listed as 230 Dudley Rd., Newton, MA 02459, USA. The resignation was accepted by the Board on July 29, 2026.
| Particulars | Details |
|---|---|
| Name | Kush Parmar |
| DIN | 09212020 |
| Position | Independent Director |
| Effective Date | July 29, 2026 |
| Reason | Increasing commitments in the USA; residence outside India |
| Committee Memberships Ceased | Risk Management Committee, Science and Technology Committee |
Regulatory Compliance
The disclosure aligns with SEBI Master Circular no. SEBI/HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026. Under Para A(7B) of Part A of Schedule III of the SEBI Listing Regulations, Parmar confirmed that he holds no directorships in other listed entities at the time of his resignation. He further affirmed that there are no undisclosed material reasons for his departure.
The Board expressed appreciation for Parmar’s contributions, independent judgment, and commitment during his tenure. The full details of the resignation, including the letter of resignation, have been made available on the company’s website.
Historical Stock Returns for Syngene International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.97% | +0.84% | -0.06% | -7.02% | -39.13% | -31.66% |
Has Syngene International initiated the search for a replacement Independent Director to fill the vacancy on the Risk Management and Science and Technology Committees?
How might the loss of Kush Parmar's expertise in science and technology impact Syngene's strategic oversight of its R&D pipeline?
Are there any pending regulatory approvals or board decisions that could be delayed due to the temporary reduction in independent director count?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
